Peter A. Revill

792 Elizabeth St
Melbourne, VIC 3000, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 81 publications

Corrigendum to "Overview of gene editing strategies against HBV" [Antivir. Res. 247 (2026) 106355].

Corrigendum to "Overview of gene editing strategies against HBV" [Antivir. Res. 247 (2026) 106355].

Journal: Antiviral research

Published: July 16, 2026

Overview of gene editing strategies against HBV.

Overview of gene editing strategies against HBV.

Journal: Antiviral research

Published: December 11, 2025

Anti-HBs Immune Complex Levels: A Novel Marker of Hepatitis Flare Following Nucleos(t)ide Analog Withdrawal in HBeAg-negative Chronic Hepatitis B.

Anti-HBs Immune Complex Levels: A Novel Marker of Hepatitis Flare Following Nucleos(t)ide Analog Withdrawal in HBeAg-negative Chronic Hepatitis B.

Journal: The Journal of infectious diseases

Published: September 11, 2025

Anti-HBs immune complex levels: A novel marker of hepatitis flare following nucleos(t)ide analogue withdrawal in HBeAg-negative chronic hepatitis B.

Anti-HBs immune complex levels: A novel marker of hepatitis flare following nucleos(t)ide analogue withdrawal in HBeAg-negative chronic hepatitis B.

Journal: The Journal of infectious diseases

Published: September 11, 2025

Hepatitis B surface antigen is upregulated by HIV Tat in an HIV-hepatitis B virus co-infection model system.

Hepatitis B surface antigen is upregulated by HIV Tat in an HIV-hepatitis B virus co-infection model system.

Journal: Microbiology spectrum

Published: July 23, 2025

Kinetics and Predictors of Hepatitis B Surface Antigen Loss After Commencing Hepatitis B Virus (HBV)-Active Antiretroviral Therapy in the Setting of HIV and Chronic HBV Coinfection.

Kinetics and Predictors of Hepatitis B Surface Antigen Loss After Commencing Hepatitis B Virus (HBV)-Active Antiretroviral Therapy in the Setting of HIV and Chronic HBV Coinfection.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: December 02, 2024

Availability of point-of-care HBV tests in resource-limited settings.

Availability of point-of-care HBV tests in resource-limited settings.

Journal: The lancet. Gastroenterology & hepatology

Published: September 01, 2024

Highlights from the 2023 International Meeting on the Molecular Biology of Hepatitis B virus.

Highlights from the 2023 International Meeting on the Molecular Biology of Hepatitis B virus.

Journal: The Journal of general virology

Published: May 17, 2024

The in vitro replication phenotype of hepatitis B virus (HBV) splice variants Sp3 and Sp9 and their impact on wild-type HBV replication.

The in vitro replication phenotype of hepatitis B virus (HBV) splice variants Sp3 and Sp9 and their impact on wild-type HBV replication.

Journal: Journal of virology

Published: March 19, 2024

High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy.

High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 06, 2024

CRISPR-Cas13b-mediated suppression of HBV replication and protein expression.

CRISPR-Cas13b-mediated suppression of HBV replication and protein expression.

Journal: Journal of hepatology

Published: September 26, 2023

Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".

Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".

Journal: mBio

Published: April 25, 2023

Showing 1-12 of 81

Last Updated: 09/26/2026